The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells

Prostate cancer

(2021) Richard J. Rebello et al.   Nature Reviews Disease Primers

Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses

(2021) Fan Huang et al.   JOURNAL OF CLINICAL INVESTIGATION

Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial

(2021) Christopher Sweeney et al.   LANCET

Biglycan: an emerging small leucine-rich proteoglycan (SLRP) marker and its clinicopathological significance

(2021) Sandeep Appunni et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence

(2021) Jianjiang Fu et al.   ONCOGENE

HER3 Is an Actionable Target in Advanced Prostate Cancer

(2021) Veronica Gil et al.   CANCER RESEARCH

Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis

(2021) Nicolò Pernigoni et al.   SCIENCE

Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression

(2021) Marco Bolis et al.   Nature Communications

Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study

(2021) R. de Wit et al.   ESMO Open

CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo

(2020) Abdullah Alajati et al.   JOURNAL OF CLINICAL INVESTIGATION

SMN-primed ribosomes modulate the translation of transcripts related to spinal muscular atrophy

(2020) Fabio Lauria et al.   NATURE CELL BIOLOGY

Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis

(2020) Ilaria Guccini et al.   CANCER CELL

MNK inhibition sensitizes KRAS-mutant colorectal cancer to mTORC1 inhibition by reducing eIF4E phosphorylation and c-MYC expression

(2020) John R P Knight et al.   Cancer Discovery

Translation control of the immune checkpoint in cancer and its therapeutic targeting

(2019) Yichen Xu et al.   NATURE MEDICINE

The Proteogenomic Landscape of Curable Prostate Cancer

(2019) Ankit Sinha et al.   CANCER CELL

Generally applicable transcriptome-wide analysis of translation using anota2seq

(2019) Christian Oertlin et al.   NUCLEIC ACIDS RESEARCH

Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)

(2018) Jonathan Welti et al.   CLINICAL CANCER RESEARCH

Structure-based Design of Pyridone–Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition

(2018) Siegfried H. Reich et al.   JOURNAL OF MEDICINAL CHEMISTRY

Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer

(2018) Harsimar B. Kaur et al.   MODERN PATHOLOGY

Heterogeneity and specialized functions of translation machinery: from genes to organisms

(2018) Naomi R. Genuth et al.   NATURE REVIEWS GENETICS

Clinical implications of PTEN loss in prostate cancer

(2018) Tamara Jamaspishvili et al.   Nature Reviews Urology

The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin

(2018) Christian D. Sadik et al.   SEMINARS IN IMMUNOLOGY

Translational Control in Cancer

(2018) Nathaniel Robichaud et al.   Cold Spring Harbor Perspectives in Biology

The role of osteopontin in the progression of solid organ tumour

(2018) Hailin Zhao et al.   Cell Death & Disease

Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E

(2018) Argel Aguilar-Valles et al.   Nature Communications

IL-23 secreted by myeloid cells drives castration-resistant prostate cancer

(2018) Arianna Calcinotto et al.   NATURE

Myeloid-derived suppressor cells inhibit T cell activation through nitrating LCK in mouse cancers

(2018) Shan Feng et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Fundamental Mechanisms of Immune Checkpoint Blockade Therapy

(2018) Spencer C. Wei et al.   Cancer Discovery

riboWaltz: Optimization of ribosome P-site positioning in ribosome profiling data

(2018) Fabio Lauria et al.   PLoS Computational Biology

Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma

(2018) Michaël Cerezo et al.   NATURE MEDICINE

Immunotherapy for lethal prostate cancer

(2018) Pasquale Rescigno et al.   Nature Reviews Urology

Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss

(2018) Johann S. de Bono et al.   CLINICAL CANCER RESEARCH

Extracellular ISG15 Signals Cytokine Secretion through the LFA-1 Integrin Receptor

(2017) Caleb D. Swaim et al.   MOLECULAR CELL

Effective combinatorial immunotherapy for castration-resistant prostate cancer

(2017) Xin Lu et al.   NATURE

Translation Initiation Factors: Reprogramming Protein Synthesis in Cancer

(2016) Jennifer Chu et al.   TRENDS IN CELL BIOLOGY

Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity

(2016) Qing Zhong et al.   Scientific Reports

The Molecular Taxonomy of Primary Prostate Cancer

(2015) Adam Abeshouse et al.   CELL

Targeting the translation machinery in cancer

(2015) Mamatha Bhat et al.   NATURE REVIEWS DRUG DISCOVERY

Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer

(2014) R. Leibowitz-Amit et al.   ANNALS OF ONCOLOGY

Baseline neutrophil–lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use

(2014) D. Lorente et al.   ANNALS OF ONCOLOGY

Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials†

(2014) R. J. van Soest et al.   ANNALS OF ONCOLOGY

Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio

(2014) Arnoud J. Templeton et al.   CANCER

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

(2014) Eugene D Kwon et al.   LANCET ONCOLOGY

Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer

(2014) Diletta Di Mitri et al.   NATURE

Translational control of immune responses: from transcripts to translatomes

(2014) Ciriaco A Piccirillo et al.   NATURE IMMUNOLOGY

Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3

(2014) N Robichaud et al.   ONCOGENE

Elevated IL-8, TNF-α, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival

(2014) Jaya Sharma et al.   PROSTATE

RapidCaP, a Novel GEM Model for Metastatic Prostate Cancer Analysis and Therapy, Reveals Myc as a Driver of Pten-Mutant Metastasis

(2014) H. Cho et al.   Cancer Discovery

Targeting Activated Akt with GDC-0068, a Novel Selective Akt Inhibitor That Is Efficacious in Multiple Tumor Models

(2013) J. Lin et al.   CLINICAL CANCER RESEARCH

ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss

(2013) Yu Chen et al.   NATURE MEDICINE

STAR: ultrafast universal RNA-seq aligner

(2012) Alexander Dobin et al.   BIOINFORMATICS

Widespread uncoupling between transcriptome and translatome variations after a stimulus in mammalian cells

(2012) Toma Tebaldi et al.   BMC GENOMICS

An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy

(2012) Emmanuel S. Antonarakis et al.   CANCER

Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth

(2012) Matthew R. Porembka et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

GENCODE: The reference human genome annotation for The ENCODE Project

(2012) J. Harrow et al.   GENOME RESEARCH

Increased Myeloid-Derived Suppressor Cells in Gastric Cancer Correlate with Cancer Stage and Plasma S100A8/A9 Proinflammatory Proteins

(2012) L. Wang et al.   JOURNAL OF IMMUNOLOGY

The translational landscape of mTOR signalling steers cancer initiation and metastasis

(2012) Andrew C. Hsieh et al.   NATURE

STRING v9.1: protein-protein interaction networks, with increased coverage and integration

(2012) Andrea Franceschini et al.   NUCLEIC ACIDS RESEARCH

Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway

(2012) Sandeep Sheth et al.   PLoS One

Global quantification of mammalian gene expression control

(2011) Björn Schwanhäusser et al.   NATURE

mRNA helicases: the tacticians of translational control

(2011) Armen Parsyan et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Integrative Genomic Profiling of Human Prostate Cancer

(2010) Barry S. Taylor et al.   CANCER CELL

Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription Factor

(2010) Ilaria Marigo et al.   IMMUNITY

eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression

(2010) L. Furic et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

(2009) M. D. Robinson et al.   BIOINFORMATICS

Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells

(2009) Moses K. Donkor et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21

(2009) Frederick J Sheedy et al.   NATURE IMMUNOLOGY

Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling

(2009) N. T. Ingolia et al.   SCIENCE

Translation Inhibitor Pdcd4 Is Targeted for Degradation during Tumor Promotion

(2008) T. Schmid et al.   CANCER RESEARCH